← Leaderboards
Vsevolod Y Polotsky
Johns Hopkins University
$18,607,337
Attributed
$29,343,229
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,343,229 · 14
By mechanism
R01$19,299,415 · 5
T32$4,779,955 · 1
UG3$2,104,389 · 1
P50$824,074 · 1
R61$736,818 · 1
K08$657,450 · 1
Top collaborators
- Ronald D Chervin9 shared
- Emmanuel J Mignot9 shared
- Allan Ian Pack9 shared
- James Sk Sham9 shared
- David Mendelowitz6 shared
- Alan R Schwartz4 shared
- Sean D Stocker3 shared
- Carl Neil Kraus2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Karthik Suresh$2,976,640
- Philip A Cole$22,629,551
- Harikrishna Tandri$2,960,221
- Mounya Elhilali$8,857,901
- James Sk Sham$11,220,427
Others in their field
Top investigators on “Obesity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S. Currier · University Of California Los Angeles$139,907,800
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
ObesityObstructive Sleep ApneaSleep Apnea SyndromesLeptinSleepCardiovascular SystemObese MiceMorbidity - Disease RateMortalityAttenuatedResponseReceptorAffectHormonesAirway ObstructionResistanceLeptin ReceptorChronicRecurrenceHypoxiaBreathingBrainMouse ModelPathway Interactions
Grant awards (60)
Repurposing FDA-approved oxytocin to treat opioid-induced respiratory depression$2,104,389
UG3 · FY2025 · DA
Melanocortin 4 receptor agonists to treat sleep disordered breathing in obesity$807,364
R01 · FY2025 · HL · contact PI
Leptin and intermittent hypoxia interactions in the carotid bodies: mechanisms and consequences$743,127
R01 · FY2025 · HL · contact PI
Respiratory effects of the melanocortin 4 receptor in the lateral parabrachial nucleus$43,644
R01 · FY2025 · HL · contact PI
The role of the melanocortin 4 receptor in control of breathing$41,866
R01 · FY2025 · HL · contact PI
Melanocortin 4 receptor agonists to treat sleep disordered breathing in obesity$807,364
R01 · FY2024 · HL · contact PI
Leptin signaling in the carotid body: mechanisms and consequences$572,479
R01 · FY2024 · HL · contact PI
Melanocortin 4 signaling in the carotid body in obesity$204,887
R01 · FY2024 · HL · contact PI
Treatment of Sleep Apnea by Targeting Leptin Signaling$935,579
R01 · FY2023 · HL · contact PI
Leptin signaling in the carotid body: mechanisms and consequences$634,633
R01 · FY2023 · HL · contact PI
Leptin Receptor Agonist to Treat Sleep Disordered Breathing$319,944
R41 · FY2023 · HL
Treatment of Sleep Apnea by Targeting Leptin Signaling$796,092
R01 · FY2022 · HL · contact PI
Leptin signaling in the carotid body: mechanisms and consequences$737,117
R01 · FY2022 · HL · contact PI
Leptin Receptor Agonist as a Novel Prevention of Opioid Induced Respiratory Depression$318,971
R41 · FY2022 · DA
Treatment of Sleep Apnea by Targeting Leptin Signaling$796,092
R01 · FY2021 · HL · contact PI
Leptin signaling in the carotid body: mechanisms and consequences$745,529
R01 · FY2021 · HL · contact PI
Multi-Institutional Training in Genetic/Genomic Approaches to Sleep Disorders$732,857
T32 · FY2021 · HL
Targeting Leptin Pathway to Treat Opioid-Induced Respiratory Depression$259,438
U18 · FY2021 · DA · contact PI
Treatment of Sleep Apnea by Targeting Leptin Signaling$819,889
R01 · FY2020 · HL · contact PI
Intranasal Leptin as A Novel Treatment of Opioid-Induced Respiratory Depression$622,889
R61 · FY2020 · HL · contact PI
Chemogenetic approach to treat Obstructive Sleep Apnea$592,313
R01 · FY2020 · HL · contact PI
Multi-Institutional Training in Genetic/Genomic Approaches to Sleep Disorders$488,247
T32 · FY2020 · HL
Intranasal Leptin as A Novel Treatment of Opioid-Induced Respiratory Depression$113,929
R61 · FY2020 · HL · contact PI
Leptin signaling in the carotid body: mechanisms and consequences$684,225
R01 · FY2019 · HL · contact PI
Chemogenetic approach to treat Obstructive Sleep Apnea$589,580
R01 · FY2019 · HL · contact PI
Multi-Institutional Training in Genetic/Genomic Approaches to Sleep Disorders$499,535
T32 · FY2019 · HL
Leptin signaling in the carotid body: mechanisms and consequences$684,225
R01 · FY2018 · HL · contact PI
Multi-Institutional Training in Genetic/Genomic Approaches to Sleep Disorders$667,780
T32 · FY2018 · HL
Chemogenetic approach to treat Obstructive Sleep Apnea$600,340
R01 · FY2018 · HL · contact PI
Treatment of sleep apnea by targeting leptin signaling$519,348
R01 · FY2018 · HL · contact PI
The role of obesity in biological responses to particulate matter in mice$218,485
P50 · FY2018 · ES · contact PI
Leptin signaling in the carotid body: mechanisms and consequences$684,225
R01 · FY2017 · HL · contact PI
Chemogenetic approach to treat Obstructive Sleep Apnea$600,290
R01 · FY2017 · HL · contact PI
Treatment of sleep apnea by targeting leptin signaling$519,348
R01 · FY2017 · HL · contact PI
Multi-Institutional Training in Genetic/Genomic Approaches to Sleep Disorders$321,295
T32 · FY2017 · HL
The role of obesity in biological responses to particulate matter in mice$208,961
P50 · FY2017 · ES · contact PI
Leptin signaling in the carotid body: mechanisms and consequences$684,225
R01 · FY2016 · HL · contact PI
Multi-Institutional Training in Genetic/Genomic Approaches to Sleep Disorders$663,010
T32 · FY2016 · HL
Treatment of sleep apnea by targeting leptin signaling$519,348
R01 · FY2016 · HL · contact PI
The role of obesity in biological responses to particulate matter in mice$199,995
P50 · FY2016 · ES · contact PI
Multi-Institutional Training in Genetic/Genomic Approaches to Sleep Disorders$647,009
T32 · FY2015 · HL
Treatment of sleep apnea by targeting leptin signaling$519,348
R01 · FY2015 · HL · contact PI
The role of obesity in biological responses to particulate matter in mice$196,633
P50 · FY2015 · ES · contact PI
Multi-Institutional Training in Genetic/Genomic Approaches to Sleep Disorders$509,515
T32 · FY2014 · HL
Sleep Apnea and Dysregulation of Lipid Metabolism$397,782
R01 · FY2014 · HL · contact PI
Sleep Apnea and Dysregulation of Lipid Metabolism$386,417
R01 · FY2013 · HL · contact PI
Multi-Institutional Training in Genetic/Genomic Approaches to Sleep Disorders$250,707
T32 · FY2013 · HL
Sleep Apnea and Dysregulation of Lipid Metabolism$405,900
R01 · FY2012 · HL · contact PI
Sleep Apnea and Dysregulation of Lipid Metabolism$410,000
R01 · FY2011 · HL · contact PI
Sleep Apnea and Dysregulation of Lipid Metabolism$410,000
R01 · FY2010 · HL · contact PI
Sleep Apnea and Dysregulation of Lipid Metabolism$349,879
R01 · FY2008 · HL · contact PI
Sleep Apnea and Dysregulation of Lipid Metabolism$349,879
R01 · FY2007 · HL · contact PI
Sleep Apnea and Dysregulation of Lipid Metabolism$359,231
R01 · FY2006 · HL · contact PI
Sleep Disordered Breathing and Glucose Regulation$131,490
K08 · FY2006 · HL · contact PI
Sleep Apnea and Dysregulation of Lipid Metabolism$347,850
R01 · FY2005 · HL
Sleep Disordered Breathing and Glucose Regulation$131,490
K08 · FY2005 · HL
Sleep Disordered Breathing and Glucose Regulation$131,490
K08 · FY2004 · HL
Sleep Disordered Breathing and Glucose Regulation$131,490
K08 · FY2003 · HL
Sleep Disordered Breathing and Glucose Regulation$131,490
K08 · FY2002 · HL
INTERACTION OF LEPTIN AND INSULIN IN VENTILATORY CONTROL$42,775
F32 · FY2000 · HL